The 5-HT1Freceptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials

✍ Scribed by Tfelt-Hansen, Peer C.; Olesen, Jes

• Book ID: 113057979
• Publisher: Springer
• Year: 2012
• Tongue: English
• Weight: 223 KB
• Volume: 13
• Category: Article
• ISSN: 1129-2369
• DOI: 10.1007/s10194-012-0428-7